NWP
NKTR icon

Northstar Wealth Partners’s Nektar Therapeutics NKTR Stock Holding History

Northstar Wealth Partners’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$248K Hold
1,000
– – 0.12% 126
2020
Q2 		$347K Hold
1,000
– – 0.14% 129
2020
Q1 		$267K Buy
+1,000
New +$309K 0.14% 133
2018
Q4 		– Sell
-333
Closed -$304K – 174
2018
Q3 		$304K Hold
333
– – 0.15% 134
2018
Q2 		$244K Buy
+333
New +$384K 0.12% 165

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Northstar Wealth Partners's NKTR Position: Q3 2020 in Review

Northstar Wealth Partners held its Nektar Therapeutics (NKTR) position steady in Q3 2020 at 1,000 shares worth $248K. The position accounts for 0.12% of the portfolio, ranked #126.

Northstar Wealth Partners first reported a position in NKTR in Q2 2018 and has held it in 5 quarters since. The position peaked at $347K in Q2 2020. 249 funds tracked by Wall St. Rank hold NKTR as of Q3 2020.

  • Northstar Wealth Partners held 1,000 shares of Nektar Therapeutics worth $248K as of Q3 2020.
  • Northstar Wealth Partners left its Nektar Therapeutics share count unchanged in Q3 2020.
  • Nektar Therapeutics made up 0.12% of Northstar Wealth Partners's portfolio in Q3 2020, its #126 holding.
  • Northstar Wealth Partners first reported a position in Nektar Therapeutics in Q2 2018 and has held it in 5 quarters since.
  • Northstar Wealth Partners's Nektar Therapeutics position peaked at $347K in Q2 2020.
  • 249 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.